White matter alterations in the brains of patients with active, remitted, and cured cushing syndrome: A DTI study

American Journal of Neuroradiology

Volumn 36, Issue 6, 2015, Pages 1043-1048

  Pires, P ^a,b   Santos, A ^b   Vives Gilabert, Y ^a,c   Webb, S M ^b   Sainz Ruiz, A ^c,d   Resmini, E ^b   Crespo, I ^b   De Juan Delago, M ^b   Gómez Ansón, Beatriz ^b  

^a Gestión Y Procesamiento de Datos Científicos Y Tecnológicos   (Spain)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^c Also at Port d'Informació Científica PIC   (Spain)

^d BARCELONA INSTITUTE OF SCIENCE AND TECHNOLOGY   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROCORTISONE;

ADULT; ARTICLE; BODY MASS; CARDIOVASCULAR RISK; CINGULATE GYRUS; CLINICAL ARTICLE; CONTROLLED STUDY; CORTICOSTEROID THERAPY; CUSHING SYNDROME; DIFFUSION TENSOR IMAGING; DISEASE DURATION; EDUCATION; FEMALE; FRACTIONAL ANISOTROPY; HUMAN; HYPERCHOLESTEROLEMIA; HYPERCORTISOLISM; HYPERTENSION; HYPERTRIGLYCERIDEMIA; IMAGE PROCESSING; MALE; OBESITY; UNCINATE FASCICULUS; WHITE MATTER; ANISOTROPY; BRAIN; DEMYELINATING DISEASES; MIDDLE AGED; PATHOLOGY; RISK FACTOR;

ADULT; ANISOTROPY; BRAIN; CUSHING SYNDROME; DEMYELINATING DISEASES; DIFFUSION TENSOR IMAGING; FEMALE; HUMANS; MALE; MIDDLE AGED; RISK FACTORS; WHITE MATTER;

EID: 84930982560     PISSN: 01956108     EISSN: 1936959X     Source Type: Journal    
DOI: 10.3174/ajnr.A4322     Document Type: Article

References (38)

1. Newell-Price J. Cushing's syndrome. Clin Med 2008;8:204-08
2. Hatipoglu BA. Cushing's syndrome. J Surg Oncol 2012;106: 565-71
3. Guaraldi F, Salvatori R. Cushing syndrome: maybe not so uncommon of an endocrine disease. J Am Board Fam Med 2012;25: 199-208
4. Sapolsky RM, Krey LC, McEwen BS. The neuroendocrinology of stress and aging: the glucocorticoid cascade hypothesis. Endocr Rev 1986;7:284-301
5. Goosens KA, Sapolsky RM. Stress and glucocorticoid contributions to normal and pathological aging. In Riddle DR, ed. Brain Aging: Models, Methods, and Mechanisms. Boca Raton: CRC Press; 2007:305-22
6. Bohn MC, Friedrich VL Jr. Recovery of myelination in rat optic nerve after developmental retardation by cortisol. J Neurosci 1982;2:1292-98
7. Alonso G. Prolonged corticosterone treatment of adult rats inhibits the proliferation of oligodendrocyte progenitors present throughout white and gray matter regions of the brain. Glia 2000;31:219-31
8. Miyata S, Koyama Y, Takemoto K, et al. Plasma corticosterone activates SGK1 and induces morphological changes in oligodendrocytes in corpus callosum. PLoS One 2011;6:e19859
9. Fallo F, Sonino N. Should we evaluate for cardiovascular disease in patients with Cushing's syndrome? Clin Endocrinol 2009;71: 768-71
10. Aulinas A, Valassi E, Webb SM. Prognosis of patients treated for Cushing syndrome. Endocrinol Nutr 2014;61:52-61
11. Miljic P, Miljic D, Cain JW, et al. Pathogenesis of vascular complications in Cushing's syndrome. Hormones (Athens) 2012;11: 21-30
12. Trethowan WH, Cobb S. Neuropsychiatric aspects of Cushing's syndrome. AMA Arch Neurol Psychiatry 1952;67:283-309
13. Cope O, Raker JW. Cushing's disease: the surgical experience in the care of 46 cases. N Engl J Med 1955;253:119-27
14. Starkman MN, Gebarski SS, Berent S, et al. Hippocampal formation volume, memory dysfunction, and cortisol levels in patients with Cushing's syndrome. Biol Psychiatry 1992;32:756-65
15. Simmons NE, Do HM, Lipper MH, et al. Cerebral atrophy in Cushing's disease. Surg Neurol 2000;53:72-76
16. Resmini E, Santos A, Gómez-Anson B, et al. Verbal and visual memory performance and hippocampal volumes, measured by 3-Tesla magnetic resonance imaging, in patients with Cushing's syndrome. J Clin Endocrinol Metab 2012;97:663-71
17. van der Werff SJ, Andela CD, Nienke Pannekoek J, et al. Widespread reductions of white matter integrity in patients with long-term remissions of Cushing's disease. Neuroimage Clin 2014;4:659-67
18. Johansen-Berg H, Rushworth MF. Using diffusion imaging to study human connectional anatomy. Annu Rev Neurosci 2009;32: 75-94
19. Le Bihan D, Breton E, Lallemand D, et al. MR imaging of intravoxel incoherent motions: application to diffusion and perfusion in neurologic disorders. Radiology 1986;161:401-07
20. Le Bihan D. Looking into the functional architecture of the brain with diffusion MRI. Nat Rev Neurosci 2003;4:469-80
21. Alexander AL, Lee JE, Lazar M, et al. Diffusion tensor imaging of the brain. Neurotherapeutics 2007;4:316-29
22. Budde MD, Xie M, Cross AH, et al. Axial diffusivity is the primary correlate of axonal injury in the experimental autoimmune encephalomyelitis spinal cord: a quantitative pixelwise analysis. J Neurosci 2009;29:2805-13
23. Hsu JL, Chen YL, Leu JG, et al. Microstructural white matter abnormalities in type 2 diabetes mellitus: a diffusion tensor imaging study. Neuroimage 2012;59:1098-105
24. Smith SM, Jenkinson M, Woolrich MW, et al. Advances in functional and structural MR image analysis and implementation as FSL. Neuroimage 2004;23(suppl 1):S208-19
25. Smith SM. Fast robust automated brain extraction. Hum Brain Mapp 2002;17:143-55
26. Smith SM, Jenkinson M, Johansen-Berg H, et al. Tract-based spatial statistics: voxelwise analysis of multi-subject diffusion data. Neuroimage 2006;31:1487-505
27. Horsfield MA, Jones DK. Applications of diffusion-weighted and diffusion tensor MRI to white matter diseases: a review. NMR Biomed 2002;15:570-77
28. Beaulieu C. The basis of anisotropic water diffusion in the nervous system: a technical review. NMR Biomed 2002;15:435-55
29. Song SK, Yoshino J, Le TQ, et al. Demyelination increases radial diffusivity in corpus callosum of mouse brain. Neuroimage 2005;26:132-40
30. Wheeler-Kingshott CA, Cercignani M. About "axial" and "radial" diffusivities. Magn Res Med 2009;61:1255-60
31. Jones DK, Knösche TR, Turner R. White matter integrity, fiber count, and other fallacies: the do's and don'ts of diffusion MRI. Neuroimage 2013;73:239-54
32. Minati L, Grisoli M, Bruzzone MG. MR spectroscopy, functional MRI, and diffusion-tensor imaging in the aging brain: a conceptual review. J Geriatr Psychiatry Neurol 2007;20:3-21
33. Burzynska AZ, Preuschhof C, Bäckman L, et al. Age-related differences in white matter microstructure: region-specific patterns of diffusivity. Neuroimage 2010;49:2104-12
34. Bourdeau I, Bard C, Noël B, et al. Loss of brain volume in endogenous Cushing's syndrome and its reversibility after correction of hypercortisolism. J Clin Endocrinol Metab 2002;87:1949-54
35. Starkman MN, Giordani B, Gebarski SS, et al. Decrease in cortisol reverses human hippocampal atrophy following treatment of Cushing's disease. Biol Psychiatry 1999;46:1595-602
36. Resmini E, Santos A, Gómez-Anson B, et al. Hippocampal dysfunction in cured Cushing's syndrome patients, detected by (1) H-MRspectroscopy. Clin Endocrinol (Oxf) 2013;79:700-07
37. Sorrells, Sapolsky RM. An inflammatory review of glucocorticoid actions in the CNS. Brain Behav Immun 2007;21:259-72
38. Barahona MJ, Sucunza N, Resmini E, et al. Persistent body fat mass and inflammatory marker increases after long-term cure of Cushing's syndrome. J Clin Endocrinol Metab 2009;94:3365-71